Inari Medical(NARI) - 2024 Q1 - Earnings Call Presentation

Building momentum with new products in new markets • EMEA: ~20 active countries • APAC & LAC: ~12 active countries • China & Japan commercial in 2024 International global commercial playbook Commercial Playbook Venous Thromboembolism (VTE) DEEP VEIN THROMBOSIS (DVT) • Lytics don't address chronic clot, and come with bleeding risk DVT TAM 430,000 US Patients $3.0B TAM 1. Young et al., Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost 2006; 4 ...